# Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary Syndromes

> **NCT00099788** · PHASE3 · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 6560 (actual)

## Conditions studied

- Myocardial Ischemia

## Interventions

- **DRUG:** Ranolazine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00099788
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2007-02
- **Final completion:** 2007-02
- **Target enrollment:** 6560 (ACTUAL)
- **Last updated:** 2009-11-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00099788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00099788, "Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary Syndromes". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00099788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*